# Trade Mark Journal No.2025/040 3 October 2025

## WO0000001864023 (5)

Office of origin: United States of America

Date of International Registration:28 May 2025
Date of designation in the UK: 28 May 2025

International priority date claimed: 20 December 2024 (United States of America) (98915324)

Class 5
  Gene therapy products, namely, genetically engineered tissues for transplant purposes; pharmaceutical preparations for adeno-associated virus delivery to control gene expression and gene replacement; pharmaceutical preparations for adeno-associated virus to deliver corrective genes, replace defective genes or delivery therapeutic genes.

Asymptote Genetic Medicines, Inc.

Representative: Jonathan Pearce SoCal IP Law Group LLP, 310 N Westlake Blvd., Suite 120, Westlake Village CA 91362, UNITED STATES OF AMERICA